iCAD to showcase its cancer diagnostic imaging products at ECR annual meeting

iCAD, IncMar 3 2011

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's (ECR) annual meeting being held in Vienna, Austria from March 3 - 7, 2011.

"As the diagnostic imaging market continues to rebound in the U.S. and Europe, iCAD is continuing to work with leading radiologists and healthcare advocates to introduce breakthrough image analysis and computer-aided detection technologies that can help in the earlier detection of cancer," said Ken Ferry, President and CEO of iCAD. "We are excited to attend ECR and demonstrate solutions we expect will help change the diagnostic paradigm for breast, prostate and colon cancers."

Important scientific posters discussing the use of computer-aided detection (CAD) for virtual colonoscopy (CTC), iCAD's VeraLook™, will be part of the educational exhibits as electronic poster presentations. These include:

• Poster C-2335 titled "Optimizing Computer-aided Detection for CT Colonography: Understanding Stand Alone Software Accuracy," by Dr. Abraham Dachman, Professor of Radiology and Director of Fellowship Programs at the University of Chicago.
• Poster C-2336 titled, "Optimizing Time-efficient Use of Computer-aided Detection in Computed Tomographic Colonography (Virtual Colonoscopy)," by Dr. Abraham Dachman.

At ECR, iCAD will showcase several advanced image analysis and clinical decision support solutions that work with digital mammography, magnetic resonance imaging (MRI), and computed tomography (CT) imaging modalities, including:

Mammography

• SecondLook^® Premier*, the latest SecondLook Digital CAD solution from iCAD has been designed and developed using a 100 percent digital image database providing improved digital CAD performance. SecondLook Premier provides superior detection and includes clinical decision support tools such as CAD Metrics and CAD iNSIGHT to provide breast imagers with the most robust CAD solution available. The new SecondLook Premier solution offers reverse compatibility for existing GE and Siemens SecondLook digital installations.
• SecondLook^® Digital Multi Vendor Solution (MVS) from iCAD allows hospitals and imaging facilities to process cases from digital mammography systems manufactured by GE, Siemens, Agfa, Planmed, Giotto, Sectra, Fuji, and Philips using a single server for multiple vendor input devices (up to four connections per server), eliminating the need to purchase a separate server for each manufacturer's digital mammography system.

MRI

iCAD will be displaying its new MRI product suite - VividLook^®, SpectraLook^®, OmniLook™, PrecisionPoint^® and VersaVue™ Enterprise, offering a comprehensive quantitative image analysis suite for cancer detection, localization, staging, treatment planning and serial monitoring.

• VividLook DCE MRI prostate analysis solution utilizes all available time points^® (ATP), creating colorized images based on signal changes defined by tumor physiology, helping radiologists distinguish benign from malignant lesions.
• SpectraLook DCE MRI breast analysis solution is designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of the MRI data. It provides radiologists with more diagnostic information by creating colorized images based on direct signal changes due to contrast agent influx and efflux rates using key physiological measures that relate to tumor physiology.
• OmniLook, a complementary software module to iCAD's existing breast MRI (SpectraLook) and prostate MRI (VividLook) solutions, applies advanced image analysis using a pharmacokinetic model for tumor assessment in other organs, such as the liver, kidney and brain where dynamic contrast imaging may provide additional clinical insight.
• PrecisionPoint, iCAD's interventional planning solution for breast MRI, provides radiologists with an automatic calculation of the location and depth of a targeted region of interest making biopsies easier, faster, and more reliable. Using VersaVue Enterprise, iCAD's MRI review software solution and PrecisionPoint, radiologists have a quick, easy way to secure all the necessary data for an interventional procedure, streamlining their planning and performance of MRI-guided percutaneous breast biopsies.

CTC

• VeraLook™ is the first FDA cleared computer-aided detection (CAD) solution for virtual colonoscopy (CTC) designed to enhance clinician accuracy and effectiveness by improving their detection of colonic polyps. CAD for virtual colonoscopy has been shown to be effective in the detection of colonic polyps and to have a positive effect on reader sensitivity. VeraLook will be demonstrated on the Viatronix V3D and the TeraRecon AQI workstations.